Achieve Life Sciences, a pharmaceutical company developing the first vaping addiction treatment, has announced a new CEO. It <a href="https://ir.achievelifesciences.com/news-events/press-releases/detail/206/achieve-life-sciences-announces-changes-in-executive">explained</a> that it needs a leader with substantial experience in M&amp;A and drug commercialization. Freedom Finance Global Senior Analyst Ilya Zubkov believes that this move could indicate a potential sale of Achieve.

Vaping addiction treatment developer changes CEO, possibly ahead of sale

Quotes on shares of limestone and lime products manufacturer United States Lime &amp; Minerals (USLM) dropped 14% in after-hours trading on Monday, August 26. Earlier in the day, the company <a href="https://www.sec.gov/Archives/edgar/data/82020/000120497524000015/xslF345X01/primary_doc.xml">announced</a> that board member Richard Cardin had sold 12,000 shares for just under $1 million — nearly half of the shares he owned.

Limestone manufacturer USLM slides after insider sale

In the dynamic environment seen in the U.S. stock market in recent months, dividend stocks can offer stability and steady income streams to investors, <a href="https://finance.yahoo.com/news/top-us-dividend-stocks-august-110844443.html">points out</a> Simply Wall St. Their team has identified three small-cap stocks that could serve as such a safe haven.

Simply Wall St recommends three dividend stocks for investors seeking stability

Quotes on Hong Kong-based Asian food producer DayDayCook (DDC) jumped 8% in premarket trading in New York today, Monday, August 26. This comes after a Friday <a href="https://ir.daydaycook.com/news-events/press-releases/detail/22/ddc-enterprise-ltd-announces-the-closing-of-4-8m-loan-restructuring">announcement</a> that DDC had restructured a $4.8 million loan and completed a $1.7 million private placement to bolster its balance sheet.

Stock of Asian food company DDC jumps after loan restructuring announced

Benzinga has <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40447799/small-caps-soar-3-russell-2000-stocks-doubling-investor-wealth-in-2024">spotlighted</a> three stocks from the Russell 2000 Index that have at least doubled in value in 2024: the fintech company Dave, the voice AI and speech recognition company  SoundHound AI, and the large language model developer Innodata. Meanwhile, Wall Street analysts foresee further growth for all three.

Benzinga spotlights three small-cap stocks that have doubled in 2024

Small-cap stocks historically shine in U.S. presidential election years, <a href="https://www.royceinvest.com/insights/2024/3Q24/small-caps-historically-shine-in-presidential-election-years">points out</a> Francis Gannon, co-CIO at Royce Investment Partners, 98% of whose assets under management are <a href="https://kz.kursiv.media/2024-08-15/mrdr-royce/">invested</a> in small caps.

Small caps outperform large caps in election years — Royce Investment Partners

The pharmaceutical industry is one of the most challenging sectors, as bringing a drug to market takes 10-15 years and costs billions of dollars. However, the founders of Citius Pharmaceuticals seem to have found a shortcut. Its first drug is set to hit the market before the end of the year, and analysts believe that the company's stock is massively undervalued.

How to build a company in the pharmaceutical industry: Three principles of small-cap Citius Pharma

This summer has been tumultuous for investors, marked by a <a href="https://kz.kursiv.media/2024-07-26/mrdr-jpmorgan/">rotation</a> out of big tech and into other sectors and small-cap stocks, as well as the more recent <a href="https://kz.kursiv.media/2024-08-05/lktv-panic-selloff/">global</a> stock market selloff. In this dynamic environment, stocks with strong fundamentals and growth potential can "uncover hidden opportunities for investors," <a href="https://finance.yahoo.com/news/unveiling-3-undiscovered-gems-strong-110732364.html">writes</a> Simply Wall St. Their team has found three "undiscovered gems" in the market.

Simply Wall St spotlights three small stocks with ‘strong potential’

On Tuesday, August 20, Sidus Space <a href="https://investors.sidusspace.com/news-events/press-releases/detail/197/sidus-space-awarded-2-million-contract-for-u-s-navy">announced</a> that it had secured a $2 million contract to develop and test interactive display equipment for the U.S. Navy. The company, whose technology is used by businesses and governments to collect space-based data, was founded by Carol Craig, one of the first women eligible to fly in combat aircraft as a U.S. Naval flight officer. Over the last five days, Sidus Space stock has risen 20%, though it is still down 67% for the year to date.

Sidus Space secures $2 million contract for U.S. Navy program

Gryphon Digital Mining, a small company that brands itself as a carbon-neutral Bitcoin miner, has <a href="https://ir.gryphondigitalmining.com/news-events/press-releases/detail/27/gryphon-acquires-ultra-low-cost-power-mining-operations-at-~0-01kwh">announced</a> that it entered into an agreement to acquire "ultra low-cost power" assets. It expects to obtain electricity at $0.01 per kilowatt-hour (kWh). According to its own estimates, this could generate up to $1 million in annual revenue.

Low-cost power acquisition expected to add $1 million in annual revenue for Bitcoin miner Gryphon

Shares of several small diagnostics companies surged on Monday, August 19, amid what is expected to be a "dramatic increase" in demand for their tests to detect the monkeypox virus, <a href="https://seekingalpha.com/news/4141679-mpox-test-makers-end-day-huge-gains-disease-spreads">noted</a> Seeking Alpha. The outbreak has spread beyond Africa, with the first case of the latest strain <a href="https://ru.euronews.com/health/2024/08/15/health-sweden-first-mpox-case">reported</a> in Sweden last week. Meanwhile, the World Health Organization (WHO) has <a href="https://news.un.org/ru/story/2024/08/1455271">announced</a> that it is urgently scaling up support to affected countries to contain the spread of the virus.

Shares of small diagnostics companies soar amid spread of monkeypox

Canadian biotech company Lexaria Bioscience has <a href="https://ir.lexariabioscience.com/news-events/press-releases/detail/259/positive-results-from-lexarias-molecular-characterization">announced</a> positive findings from a study that could potentially allow Denmark’s Novo Nordisk to reduce production costs for its type 2 diabetes and obesity drugs. The study revealed that Lexaria DehydraTECH-processed semaglutide is just as effective as the semaglutide that serves as the active ingredient in Novo Nordisk’s Ozempic injection pens and Rybelsus tablets, for which the Danish company paid about $1.8 billion back in 2020. Following this news, Lexaria stock rose more than 6% in after-hours trading on Monday. Over the last year, the share price has now tripled.